These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 2525772)

  • 21. Erythropoietin for anemia.
    Med Lett Drugs Ther; 1989 Sep; 31(801):85-6. PubMed ID: 2671624
    [No Abstract]   [Full Text] [Related]  

  • 22. Human recombinant erythropoietin (rHuEPO) in the treatment of anemia in patients with chronic renal failure (CRF): experience with a group of patients on chronic haemodialysis treatment.
    Ramírez B; Flores A; Pérez F; Córdoba C; García L; Vázquez G
    Transplant Proc; 1991 Apr; 23(2):1833-4. PubMed ID: 2053170
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of recombinant human erythropoietin on the anemia of chronic renal failure.
    Urabe A; Takaku F; Mizoguchi H; Kubo K; Ota K; Shimizu N; Tanaka K; Mimura N; Nihei H; Koshikawa S
    Int J Cell Cloning; 1988 May; 6(3):179-91. PubMed ID: 3397592
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant human erythropoietin (rHuEPO) in the treatment of anaemia of chronic renal failure.
    Desai JD; Shah BV
    J Assoc Physicians India; 1991 Jun; 39(6):483-5. PubMed ID: 1938855
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment of renal anemia using synthetic human erythropoietin].
    Blumberg A; Zehnder C
    Ther Umsch; 1988 Dec; 45(12):895-9. PubMed ID: 3065970
    [No Abstract]   [Full Text] [Related]  

  • 26. Case management of the anemic patient. Focus on blood pressure and rHuEPO therapy.
    Holechek MJ; Watson AJ
    ANNA J; 1990 Feb; 17(1):72-3. PubMed ID: 2317107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Once-weekly epoetin-beta in renal anemia: the clinical evidence.
    Albertazzi A
    Contrib Nephrol; 2002; (137):408-11. PubMed ID: 12101986
    [No Abstract]   [Full Text] [Related]  

  • 28. [Recombinant human erythropoietin in the treatment of the anemia of multiple myeloma with kidney failure].
    Arenas Gracia M; Abad Gosálvez A; Colomina Avilés J; Pascual Pérez R; Ferriz Moreno P
    An Med Interna; 1995 Apr; 12(4):187-8. PubMed ID: 7620064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does treatment of predialysis patients with recombinant human erythropoietin compromise renal function?
    Koene RA; Frenken LA
    Contrib Nephrol; 1990; 87():105-12. PubMed ID: 2093536
    [No Abstract]   [Full Text] [Related]  

  • 30. The anemia of chronic renal failure: pathophysiology and effects of recombinant erythropoietin.
    Eschbach JW; Haley NR; Adamson JW
    Contrib Nephrol; 1990; 78():24-36; discussion 37. PubMed ID: 2225841
    [No Abstract]   [Full Text] [Related]  

  • 31. EPO--one year later. Fighting anemia in the courtroom.
    Riley JB; Pristave RJ
    Nephrol News Issues; 1990 May; 4(5):27. PubMed ID: 2348877
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of anaemia in CAPD patients with recombinant human erythropoietin.
    Ramello A; Malcangi U; Bruno M; Perosa P; Reina E; Rizzuto A; Nasini MG; Carozzi S
    Adv Perit Dial; 1990; 6():308-11. PubMed ID: 1982834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant human erythropoietin.
    Schwenk MH; Halstenson CE
    DICP; 1989; 23(7-8):528-36. PubMed ID: 2669369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rate of progression of chronic renal failure in predialysis patients treated with erythropoietin.
    Abels R
    Semin Nephrol; 1990 Mar; 10(2 Suppl 1):20-5. PubMed ID: 2192413
    [No Abstract]   [Full Text] [Related]  

  • 35. The use of recombinant erythropoietin in the treatment of the anemia of chronic renal failure.
    Eschbach JW; Haley NR; Adamson JW
    Ann N Y Acad Sci; 1989; 554():225-30. PubMed ID: 2660674
    [No Abstract]   [Full Text] [Related]  

  • 36. Darbepoetin alfa administered every other week maintains hemoglobin levels over 52 weeks in patients with chronic kidney disease converting from once-weekly recombinant human erythropoietin: results from simplify the treatment of anemia with Aranesp (STAAR).
    Hertel J; Locay H; Scarlata D; Jackson L; Prathikanti R; Audhya P
    Am J Nephrol; 2006; 26(2):149-56. PubMed ID: 16636531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of renal anemia with recombinant human erythropoietin.
    Schaefer RM; Hörl WH; Massry SG
    Am J Nephrol; 1989; 9(5):353-62. PubMed ID: 2679093
    [No Abstract]   [Full Text] [Related]  

  • 38. Erythropoietin: issues in its use as a therapeutic for the anemia of chronic renal failure.
    Eschbach JW; Adamson JW
    Blood Purif; 1990; 8(5):239-54. PubMed ID: 2091684
    [No Abstract]   [Full Text] [Related]  

  • 39. [The recovery of erythropoiesis after the short-term Recormon treatment of renal anemia].
    Nikolaev AIu; Klepikov PV; Lashutin SV
    Ter Arkh; 1992; 64(6):90-1. PubMed ID: 1440349
    [No Abstract]   [Full Text] [Related]  

  • 40. [Recombinant human erythropoietin and chronic kidney failure: current situation and therapeutic implications].
    Romero González R; Torquet Escuder P
    Med Clin (Barc); 1990 Nov; 95(17):656-9. PubMed ID: 2089205
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.